For hospital use only. The recommended adult dosage of ENTEREG is 12 mg administered 30 minutes to 5 hours prior to surgery followed by 12 mg twice daily beginning the day after surgery for a maximum of 7 days or until discharge. Patients should not receive more than 15 doses of ENTEREG.
Geriatric Use: No dosage adjustment is necessary in elderly patients    [see Use in Specific Populations].
Hepatic Impairment: No dosage adjustment is necessary in patients    with mild-to-moderate hepatic impairment (Child-Pugh Class A and B). ENTEREG    is not recommended for use in patients with severe hepatic impairment (Child-Pugh    Class C) [see Use in Specific Populations     and CLINICAL PHARMACOLOGY].
Renal Impairment: No dosage adjustment is necessary in patients    with mild-to-severe renal impairment, but they should be monitored for adverse    effects. ENTEREG is not recommended for use in patients with end-stage renal    disease. [see Use in Specific Populations     and CLINICAL PHARMACOLOGY].
Race: No dosage adjustment is necessary in Black, Hispanic and    Japanese patients, however, due to observed 2-fold greater ENTEREG plasma concentrations    in healthy male Japanese subjects, Japanese patients should be monitored for    possible adverse effects. [see Use in Specific    Populations  and CLINICAL PHARMACOLOGY]
